Loading IPO status…
| Industry | Healthcare Technology |
| Stage | Series C |
| IPO Status | Private |
| Valuation | $5B |
| Total Funding | $876M |
| Headquarters | New York, NY |
| IPO Readiness Score | 48/100 |
| Founded | 2017 |
Track Ro IPO status, valuation updates, and S-1 filing milestones on TechStackIPO.
Ro has an IPO readiness score of 48/100 on TechStackIPO. A moderate readiness score suggests the company may be 2–4 years from IPO.
Ro's last known private valuation is $5B. IPO valuations typically reflect current market conditions at time of listing and may differ from private market valuations.
Pre-IPO access options may include: (1) secondary market platforms such as Forge Global or EquityZen that facilitate private share sales, (2) ETFs holding pre-IPO companies or venture portfolios, and (3) direct secondary share purchases if eligible as an accredited investor. TechStackIPO tracks availability but does not facilitate investments.